These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 33297819)

  • 1. Awareness and Use of Contraceptive Methods and Perceptions of Long-Acting Reversible Contraception Among White and Non-White Women.
    Lin CJ; Maier J; Nwankwo C; Burley C; deBorja L; Aaraj YA; Lewis E; Rhem M; Nowalk MP; South-Paul J
    J Womens Health (Larchmt); 2021 Sep; 30(9):1313-1320. PubMed ID: 33297819
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial and ethnic differences in patterns of long-acting reversible contraceptive use in the United States, 2011-2015.
    Kramer RD; Higgins JA; Godecker AL; Ehrenthal DB
    Contraception; 2018 May; 97(5):399-404. PubMed ID: 29355492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
    Coates C; Gordon CM; Simpson T
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interactive website to aid young women's choice of contraception: feasibility and efficacy RCT.
    Stephenson J; Bailey JV; Blandford A; Brima N; Copas A; D'Souza P; Gubijev A; Hunter R; Shawe J; Rait G; Oliver S
    Health Technol Assess; 2020 Nov; 24(56):1-44. PubMed ID: 33164729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Education About the Affordable Care Act Contraceptive Coverage Requirement Increases Interest in Using Long-Acting Reversible Contraception.
    Durante JC; Woodhams EJ
    Womens Health Issues; 2017; 27(2):152-157. PubMed ID: 28063850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
    Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
    Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do women and health care professionals view hormonal long-acting reversible contraception? Results from an international survey.
    Faustmann T; Crocker J; Moeller C; Engler Y; Caetano C; Buhling KJ
    Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):422-429. PubMed ID: 31559869
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
    Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
    Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
    Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
    Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of Long-Acting Reversible Contraception Among Adolescents and Young Adults.
    Santibenchakul S; Tschann M; Carlson ADP; L Hurwitz E; Salcedo J
    J Midwifery Womens Health; 2019 Mar; 64(2):194-200. PubMed ID: 30570219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study.
    Ma R; Cecil E; Bottle A; French R; Saxena S
    PLoS Med; 2020 Sep; 17(9):e1003333. PubMed ID: 32925909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
    Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
    Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial.
    Mazza D; Watson CJ; Taft A; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Black KI
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S921.e1-S921.e13. PubMed ID: 31837291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.